Murali Venugopalan
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Estrogen and related hormone effects, MicroRNA in disease regulation, Protein Kinase Regulation and GTPase Signaling, Pancreatic and Hepatic Oncology Research, Cancer Cells and Metastasis
Most-Cited Works
- → Identification of an Estrogen Response Element Activated by Metabolites of 17β-Estradiol and Raloxifene(1996)429 cited
- → Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues: Highly Potent Selective Estrogen Receptor Modulators(1998)126 cited
- Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.(1991)
- → Identification of an Estrogen Response Element Activated by Metabolites of 17 beta-Estradiol and Raloxifene(1997)56 cited
- → Inhibition of MG-63 cell proliferation and PDGF-stimulated cellular processes by inhibitors of phosphatidylinositol 3-kinase(1997)32 cited
- → Correction: Raloxifene Response Needs More Than an Element(1997)30 cited
- → Loss of Heterozygosity in Squamous Cell Carcinomas of the Head and Neck Defines a Tumor Suppressor Gene Region on 11q13(1998)24 cited
- → Efficacy and safety of on‐demand tadalafil for the treatment of erectile dysfunction in South‐East Asian men(2006)20 cited
- → Calcitonin responsiveness and receptor expression in porcine and murine osteoclasts: a comparative study(1998)12 cited
- → Selective estrogens can regulate estrogen receptor-mediated gene transcription through distinct genomic seouences(1996)